Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Diisopropylethylamine | HCID 81531 | — |
| Reactant | Methanaminium, N-((dimethylamino)(3H-1,2,3-triazolo(4,5-b)pyridin-3-yloxy)methylene)-N-methyl-, hexafluorophosphate(1-) (1:1) | HCID 9886157 | — |
| Reactant | 1-(cyclohexylmethyl)-2-(1,1-dimethylpropyl)-1H-benzimidazole-5-carboxylic acid | HCID 57636258 | — |
| Reactant | HCID 68962815 | HCID 68962815 | — |
| Solvent | Water | HCID 962 | — |
| Solvent | Dimethylformamide | HCID 6228 | — |
| Product | HCID 11395852 | HCID 11395852 | 87.5% |
Reaction Steps
Following the same procedure in Example 3, Step A, using (4R)-4-methylisoxazolidin-4-ol hydrochoride (36.0 mg, 0.25 mmol), diisopropylethylamine (144 μL, 106.6 mg, 0.83 mmol) and a solution of 1-(cyclohexylmethyl)-2-(1,1-dimethylpropyl)-1H-benzimidazole-5-carboxylic acid (82.1 mg, 0.25 mmol) (for preparation, see in Example 4, Step E) in DMF (5 mL) at 0° C., and later, HATU ( 14.0 mg, 0.30 mmol). The mixture was stirred for 4 h at room temperature, added H2O (5 mL). Upon evapoartion, the desired title compound was purified by reversed-phase HPLC (C-18 column) using 20-50% CH3CN/H2O to give 90.5 mg (69%) of a white solid. [a]D: +16.6° (c 0.15,EtOH). 1H NMR (400 MHz, CD3OD): δ 0.86 (t, J=7.42 Hz, 3H), 1.26 (m, 5H), 1.50 (s, 3H), 1.66 (m, 3H), 1.69 (s, 6H), 1.79 (m, 2H), 2.04 (q, J=7.49 Hz, 2H), 2.13 (m, 1H), 3.82 (d, J=11.33 Hz, 1H), 3.89 (d, J=8.40 Hz, 1H), 3.97 (m, 2H), 4.50 (d, J=7.81 Hz, 2H), 7.99 (m,2H), 8.19 (s, 1H). MS (ESI) (M+H)+=414.2. Anal. Calcd for C24H35N3O3+1.50 TFA+1.10 H2O (604.42): C, 53.65; H, 6.45; N, 6.95. Found: C, 53.55; H, 6.44; N, 7.18.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US07517898B2 |
|---|
| Source dataset | uspto-grants-2009_04 |
|---|
| ORD ID | ord-551b06f5230949039dcffc108d258935 |
|---|
| Source note | uspto-grants-2009_04 |
|---|